APA

Desheva J. A., Lu X. H., Rekstin A. R., Rudenko L. G., Swayne D. E., Cox N. J., Katz J. M. & Klimov A. I. (20070104). Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. : Vaccine.

Chicago

Desheva J A, Lu X H, Rekstin A R, Rudenko L G, Swayne D E, Cox N J, Katz J M and Klimov A I. 20070104. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. : Vaccine.

Harvard

Desheva J. A., Lu X. H., Rekstin A. R., Rudenko L. G., Swayne D. E., Cox N. J., Katz J. M. and Klimov A. I. (20070104). Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. : Vaccine.

MLA

Desheva J A, Lu X H, Rekstin A R, Rudenko L G, Swayne D E, Cox N J, Katz J M and Klimov A I. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. : Vaccine. 20070104.